Mitochondrial genome instability in cancer

Cytogenetic and Genome Research

Volumn 128, Issue 1-3, 2010, Pages 66-76

  Bianchi, Néstor O ^a  

^a Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

Human mitochondria cancer; Mitochondrial mutation tumors; Mt Cross talk oncogenesis

Indexed keywords

4 NITROQUINOLINE 1 OXIDE; 8 HYDROXYDEOXYGUANOSINE; CYTOCHROME C OXIDASE; CYTOCHROME C OXIDASE 2; DNA DIRECTED DNA POLYMERASE GAMMA; FUMARATE HYDRASE; GENE PRODUCT; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 1BETA; MITOCHONDRIAL DNA; PROTEIN APE1; PROTEIN NAT2; PROTEIN OGG1; PROTEIN P53; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SUCCINATE DEHYDROGENASE; SUCCINATE DEHYDROGENASE (UBIQUINONE); UBIQUINOL CYTOCHROME C REDUCTASE; UNCLASSIFIED DRUG; Y BOX BINDING PROTEIN 1;

ALCOHOL CONSUMPTION; ALLELE; AMINO ACID SUBSTITUTION; BREAST CANCER; CANCER RISK; CARCINOGENESIS; DNA ADDUCT; DNA DAMAGE; ETHNICITY; EXCISION REPAIR; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOMIC INSTABILITY; HELICOBACTER INFECTION; HETEROPLASMIC MUTATION; HOMOPLASMIC MUTATION; HUMAN; MALIGNANT TRANSFORMATION; MISMATCH REPAIR; MITOCHONDRIAL GENOME; MITOCHONDRION; MUTATION RATE; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; OXIDATIVE PHOSPHORYLATION; PHYLOGENY; PRECANCER; PRIORITY JOURNAL; PROSTATE CANCER; RESPIRATORY CHAIN; REVIEW; SEMINOMA; SOMATIC MUTATION; TRINUCLEOTIDE REPEAT; TUMOR PROMOTION;

ANIMALS; GENETIC PREDISPOSITION TO DISEASE; GENOME, MITOCHONDRIAL; GENOMIC INSTABILITY; HUMANS; MITOCHONDRIA; NEOPLASMS;

EID: 77953292059     PISSN: 14248581     EISSN: None     Source Type: Journal    
DOI: 10.1159/000300567     Document Type: Review

References (79)

1. Aikhionbare FO, Mehrabi S, Kumaresan K, Zavareh M, Olatinwo M, Odunsi K, Partridge E: Mitochondrial DNA sequence variants in epithelial ovarian tumor subtypes and stages. J Carcinog 6: 1-7 (2007).
2. Alberio S, Mineri R, Tiranti V, Zeviani M: Depletion of mtDNA: syndromes and genes. Mitochondrion 7: 6-12 (2007).
3. Arnold RS, Sun CO, Richards JC, Grigoriev G, Coleman IM, et al: Mitochondrial DNA mutation stimulates prostate cancer growth in bone stromal environment. Prostate 69: 1-11 (2009).
4. Bai RK, Leal SM, Covarrubias D, Liu A, Wong IJ: Mitochondrial genetic background modifies breast cancer risk. Cancer Res 67: 4687-4694 (2007).
5. Bianchi MS, Bianchi NO, Bailliet G: Mitochondrial DNA mutations in normal and tumor tissues from breast cancer patients. Cytogenet Cell Genet 71: 99-103 (1995).
6. Bianchi NO, Bianchi MS, Richard SM: Mitochondrial genome instability in human cancers. Mutat Res 488: 9-23 (2001).
7. Blomberg-Jensen M, Leffers H, Peterson JH, Daugaard G, Skakkebaek NE, Rajpert-De-Mayts E: Association of the polymorphism of the CAG repeat in the mitochondrial DNA polymerase gamma gene (POLG) with testicular germ-cell cancer. Ann Oncol 19: 1910-1914 (2008).
8. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, et al: A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58: 5248-5257 (1998).
9. Calvo S, Jain M, Xie X, Sheth SA, Chang B, et al: Systematic identification of human mitochondrial disease genes through integrative genomics. Nat Genet 38: 576-582 (2006).
10. Canter JA, Kallianpur AR, Parl FF, Millikan RC: Mitochondrial DNA G10398A polymorphism and invasive breast cancer in African-American women. Cancer Res 65: 8028-8033 (2005).
11. Carew JS, Huang P: Mitochondrial defects in cancer. Mol Cancer 1: 9-20 (2002).
12. Chang SC, Lin PC, Yang SH, Wang HS, Liang WY, Lin JK: Mitochondrial D-loop mutation is a common event in colorectal cancers with p53 mutations. Int J Colorectal Dis 24: 623-628 (2009).
13. Clayton DA, Doda JN, Friedberg EC: The absence of a pyrimidine dimer repair mechanism in mammalian mitochondria. Proc Natl Acad Sci USA 71: 2777-2781 (1974).
14. Coller HA, Khrapko K, Bodyak ND, Nekhaeva E, Herrero-Jimenez P, Thilly WG: High frequency of homoplasmic mitochondrial DNA mutations in human tumors can be explained without selection. Nat Genet 28: 147-150 (2001).
15. Cotton SC, Sharp L, Little J, Brockton N: Glutathione S-transferase polymorphisms and colorectal cancer: a HuGE review. Am J Epidemiol 151: 7-32 (2000). (Pubitemid 30470391)
16. Darvishi K, Sharma S, Bhat AK, Rai E, Bamezai RN: Mitochondrial DNA G10398A polymorphism imparts maternal haplogroup N a risk for breast and esophageal cancer. Cancer Lett 249: 249-255 (2007).
17. de la Chapelle A, Peltomäki P: The genetics of hereditary common cancers. Curr Opin Genet Dev 8: 298-303 (1998).
18. de Souza-Pinto NC, Mason PA, Hashiguchi K, Weissman L, Tian J, et al: Novel DNA mismatch-repair activity involving YB-1 in human mitochondria. DNA Repair 8: 704-719 (2009).
19. Delsite R, Kachhap S, Anbazhagan R, Gabrielson E, Singh KK: Nuclear genes involved in mitochondria-to-nucleus communication in breast cancer cells. Mol Cancer 1: 6-15 (2002).
20. DiMauro S, Schon EA: Mitochondrial respiratory-chain diseases. N Engl J Med 348: 2656-2668 (2003).
21. Dizdaroglu M: Chemical determination of free radical-induced damage to DNA. Free Radic Biol Med 10: 225-242 (1991).
22. Dobson AW, Xu Y, Kelley MR, LeDoux SP, Wilson GL: Enhanced mitochondrial DNA repair and cellular survival after oxidative stress by targeting the human 8-oxoguanine glycosylase repair enzyme to mitochondria. J Biol Chem 275: 37518-37523 (2000).
23. Eng C, Kiuru M, Fernández MJ, Aaltonen LA: A role for mitochondrial enzymes in inherited neoplasia and beyond. Nat Rev Cancer 3: 193-202 (2003).
24. Gene Nomenclature Committee: http://www. gene.ucl.ac.uk/nomenclature/ Arylamine Nacetyltranferase (2008).
25. Gochhait S, Bhatt A, Sharms S, Singh YP, Gupta P, Bamezai RN: Concomitant presence of mutations in mitochondrial genome and p53 in cancer development - a study in north Indian sporadic breast and esophageal cancer patients. Int J Cancer 123: 2580-2586 (2008).
26. Greaves LC, Preston SL, Tadrous PJ, Taylor RW, Barron MJ, et al: Mitochondrial DNA mutations are established in human colonic stem cells, and mutated clones expand by crypt fission. Proc Natl Acad Sci USA 103: 714-719 (2006).
27. Hiyama T, Tanaka S, Shima H, Kose K, Tuncel H, et al: Somatic mutation in mitochondrial DNA and nuclear microsatellite instability in gastric cancer. Oncol Rep 10: 1837-1841 (2003).
28. Holley AK, St Clair DK: Watching the watcher: regulation of p53 by mitochondria. Future Oncol 5: 117-130 (2009).
29. Hudson G, Chinnery PF: Mitochondrial DNA polymerase-and human disease. Human Mol Genet (review issue) 15:R244-R252 (2006).
30. Hyun JW, Choi JY, Zeng HH, Lee YS, Kim HS, Yoon SH, Chung MH: Leukemic cell line, KG-1 has a functional loss of hOGG1 enzyme due to a point mutation and 8-hydroxyguanosine can kill KG-1. Oncogene 19: 4476-4479 (2000).
31. Jakupciak JP, Maragh S, Markowitz ME, Greenberg AK, Hoque MO, et al: Performance of mitochondrial DNA mutations detecting early stage cancer. BMC Cancer 8: 285 (2008).
32. Kim MM, Glazer CA, Mambo E, Chatterjee A, Zhao M, Sidransky D, Califano JA: Head and neck cancer cell lines exhibit differential mitochondrial repair deficiency in response to 4NQO. Oral Oncol 42: 201-207 (2006).
33. Kohno T, Shinmura K, Tosaka M, Tani M, Kim SR, et al: Genetic polymorphisms and alternative splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNA. Oncogene 16: 3219-3225 (1998).
34. LeDoux SP, Wilson GL, Beecham EJ, Stevnsner T, Wassermann K, Bohr VA: Repair of mitochondrial DNA after various types of DNA damage in Chinese hamster ovary cells. Carcinogenesis 13: 1967-1973 (1992).
35. Lee J, Sharma S, Kim J, Ferrante RJ, Ryu H: Mitochondrial nuclear receptors and transcription factors: who's minding the cell? J Neurosci Res 86: 961-971 (2008).
36. Lehtonen HJ, Mäkinen MJ, Kiuru M, Laiho P, Herva R, et al: Increased HIF1 in SDH and FH deficient tumors does not cause microsatellite instability. Int J Cancer 121: 1386-1389 (2007).
37. Liu VW, Shi HH, Cheung AN, Chiu PM, Leung TW, et al: High incidence of somatic mitochondrial DNA mutations in human ovarian carcinomas. Cancer Res 61: 5998-6001 (2001).
38. Machado AM, Figueiredo C, Touati E, Máximo V, Sousa S, et al: Helicobacter pylori infection induces genetic instability of nuclear and mitochondrial DNA in gastric cells. Clin Cancer Res 15: 2995-3002 (2009).
39. Mambo E, Nyaga SG, Bohr VA, Evans MK: Defective repair of 8-hydroxyguanine in mitochondria of MCF-7 and MDA-MB-468 human breast cancer cell lines. Cancer Res 62: 1349-1355 (2002).
40. Mambo E, Gao X, Cohen Y, Guo Z, Talalay P, Sidransky D: Electrophile and oxidant damage of mitochondrial DNA leading to rapid evolution of homoplasmic mutations. Proc Natl Acad Sci USA 100: 1838-1843 (2003).
41. Mason PA, Matheson EC, Hall AG, Lightowlers RN: Mismatch repair activity in mammalian mitochondria. Nucleic Acids Res 31: 1052-1058 (2003).
42. Matoba S, Kang JG, Patino WD, Wragg A, Boehm M, et al: P53 regulates mitochondrial respiration. Science 312: 1650-1653 (2006). MITOMAP: A human mitochondrial genome database (http://www.mitomap.org).
43. Mizutani S, Miyato Y, Shidara Y, Asoh S, Tokunaga A, Tajiri T, Ohta S: Mutations in the mitochondrial genome confer resistance of cancer cells to anticancer drugs. Cancer Sci 100: 1680-1687 (2009).
44. Namslauer I, Brzezinski P: A mitochondrial DNA mutation linked to colon cancer results in proton leaks in cytochrome c oxidase. Proc Natl Acad Sci USA 106: 3402-3407 (2009).
45. Niemi AK, Hervonen A, Hurme M, Karhunen PJ, Jylhä M, Majamaa K: Mitochondrial DNA polymorphisms associated with longevity in a Finnish population. Hum Genet 112: 29-33 (2003).
46. Ohta S: Contribution of somatic mutations in the mitochondrial genome to the development of cancer and tolerance against anticancer drugs. Oncogene 25: 4768-4776 (2006).
47. Park DI, Park SH, Kim SH, Kim JW, Cho YK, et al: Effect of Helicobacter pylori infection on the expression of DNA mismatch repair protein. Helicobacter 10: 179-184 (2005).
48. Pavicic WH, Laguens M, Richard SM: Analysis association between mitochondrial genome instability and xenobiotic metabolizing genes in human breast cancer. Mol Med 15: 160-165 (2009).
49. Peltomäki P: DNA mismatch repair and cancer. Rev Mutat Res 488: 77-85 (2000).
50. Petros JA, Baumann AK, Ruiz-Pesini E, Amin MB, Sun CQ, et al: mtDNA mutations increase tumorigenicity in prostate cancer. Proc Natl Acad Sci USA 102: 719-724 (2005).
51. Pezzotti A, Kraft P, Hankinson SE, Hunter DJ, Buring J, Cox DG: The mitochondrial A10398G polymorphism, interaction with alcohol consumption, and breast cancer risk. Plos One 4: 1-5 (2009).
52. Radicella JP, Dherin C, Desmaze C, Fox MS, Boiteux S: Cloning characterization of hOGG1 , a human homolog of the OGG1 gene of Saccharomyces cerevisiae . Proc Natl Acad Sci USA 94: 8010-8015 (1997).
53. Rebbeck TR: Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev 6: 733-743 (1997).
54. Richard SM, Bailliet G, Páez GL, Bianchi MS, Peltomäki P, Bianchi NO: Nuclear and mitochondrial genome instability in human breast cancer. Cancer Res 60: 4231-4237 (2000).
55. Richter C, Park JW, Ames BN: Normal oxidative damage to mitochondrial and nuclear DNA is extensive. Proc Natl Acad Sci USA 85: 6465-6467 (1988).
56. Salas A, Yao YG, Macaulay V, Vega A, Carracedo A, Bandelt HJ: A critical reassessment of the role of mitochondria in tumorigenesis. PloS Med 2: e296 (2005).
57. Santos C, Martínez M, Lima M, Hao YJ, Simoes N, Montiel R: Mitochondrial DNA mutations in cancer: a review. Curr Topics Med Chem 8: 1351-1366 (2008).
58. Satoh M, Kuroiwa T: Organization of multiple nucleoids and DNA molecules in mitochondria of a human cell. Exp Cell Res 196: 137-140 (1991).
59. Schapira AH: The importance of LRRK2 mutations in Parkinson disease. Arch Neurol 63: 1225-1228 (2006).
60. Selak MA, Armour SM, MacKenzie ED, Boulahbel H, Watson DG, et al: Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolylhydroxylase. Cancer Cell 7: 77-85 (2005).
61. Setiawan V: Mitochondrial DNA G10398A variant is not associated with breast cancer in African-American women. Cancer Genet Cytogenet 181: 16-19 (2008).
62. Shoffner JM, Brown MD, Torroni A, Lott MT, Cabell MF, et al: Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients. Genomics 17: 171-184 (1993).
63. Singh KK, Kulawiec M, Still I, Desouki MM, Geradts J, Matsui S: Inter-genomic cross talk between mitochondria and the nucleus plays an important role in tumorigenesis. Gene 354: 140-146 (2005).
64. Singh KK, Ayyasamy V, Owens KM, Koul MS, Vujcic M: Mutations in mitochondrial DNA polymerase-gamma promote breast tumorigenesis. J Hum Genet 1-9 (2009).
65. Spinazzola A, Zeviani M: Disorders of nuclearmitochondrial intergenomic communication. Biosci Rep 27: 39-51 (2007).
66. Spinazzola A, Zeviani M: Disorders from perturbations of nuclear-mitochondrial intergenomic cross-talk. J Int Med 265: 174-192 (2009).
67. Sui G, Zhou S, Wang J, Canto M, Lee EE, et al: Mitochondrial DNA mutations in preneoplastic lesions of the gastrointestinal tract: a biomarker for the early detection of cancer. Mol Cancer 5: 73-81 (2006).
68. Szczesny B, Hazra TK, Papaconstantinou J, Mitra S, Boldogh I: Age-dependent deficiency in import of mitochondrial DNA glycosylases required for repair of oxidatively damaged bases. Proc Natl Acad Sci USA 100: 10670-10675 (2003).
69. Taylor RW, Barron MJ, Borthwick GM, Gospel A, Chinnery PF, et al: Mitochondrial DNA mutations in human colonic crypt stem cells. J Clin Invest 112: 1351-1360 (2003).
70. Torroni A, Lott MT, Cabell MF, Chen YS, Lavergne L, Wallace DC: mtDNA and the origin of Caucasians: identification of ancient Caucasian-specific haplogroups, one of which is prone to a recurrent somatic duplication in the D-loop region. Am J Hum Genet 55: 760-776 (1994).
71. Tsai MH, Fang WH, Lin SW, Yen SJ, Chou SJ, Yang YC: Mitochondrial genomic instability in colorectal cancer: no correlation to nuclear microsatellite instability and allelic deletion of hMSH2, hMLH1, and p53 genes, but prediction of better survival for Dukes' stage C disease. Ann Surg Oncol 16: 2918-2925 (2009).
72. Turrens JF: Mitochondrial formation of reactive oxygen species. J Physiol 552: 335-344 (2003).
73. Tzen CY, Mau BL, Wu TY: ND4 mutation in transitional cell carcinoma: does mitochondrial mutation occur before tumorigenesis? Mitochondrion 7: 273-278 (2007).
74. van der Walt JM, Nicodemus KK, Martin ER, Scott WK, Nance MA, et al: Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease. Am J Hum Genet 72: 804-811 (2003).
75. van Trappen PO, Cullup T, Troke R, Swann D, Shepherd JH, et al: Somatic mitochondrial DNA mutations in primary and metastatic ovarian cancer. Gynecol Oncol 104: 129-133 (2007).
76. Wallace DC: Mitochondrial diseases in man and mouse. Science 283: 1482-1488 (1999).
77. Wang CY, Wang HW, Yao YG, Kong QP, Zhang YP: Somatic mutations of mitochondrial genome in early stage breast cancer. Int J Cancer 121: 1253-1256 (2007).
78. Zanssen S, Schon EA: Mitochondrial DNA mutations in cancer. PloS Med 2: e401 (2005).
79. Zhou S, Kachhap S, Sun W, Wu G, Chuang A, et al: Frequency and phenotypic implications of mitochondrial DNA mutations in human squamous cell cancers of the head and neck. Proc Natl Acad Sci USA 104: 7540-7545 (2007).